Catalyst

Slingshot members are tracking this event:

GlaxoSmithKline (GSK) and Johnson & Johnson (JNJ) Submit Sirukumab in Treatment of Rheumatoid Arthritis to European Medicines Agency

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
JNJ

100%
GSK

100%
SNY

100%
REGN

100%
Slingshot Insights Explained
Catalyst Date
Occurred on:
Sep 12, 2016
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Sirukumab, Rheumatoid Arthritis, European Medicines Agency, Marketing Application